Zomedica Corp. (ZOMDF)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Net revenue | 6,964 | 6,500 | ||
| Cost of revenue | 2,298 | 2,093 | ||
| Gross profit | 4,666 | 4,407 | ||
| General and administrative | 6,162 | 6,262 | ||
| Research and development | 1,886 | 1,853 | ||
| Selling and marketing | 4,653 | 5,007 | ||
| Impairment expense | - | 55,833 | ||
| Loss from operations | -8,035 | -64,548 | ||
| Interest income | 629 | 730 | ||
| (loss) gain on disposal of assets | 1 | -8 | ||
| Foreign exchange gain (loss) | 58 | 4 | ||
| Other (expense) income | -39 | -44 | ||
| Loss before income taxes | -7,386 | -63,866 | ||
| Income tax expense (benefit) | 12 | -57 | ||
| Net loss | -7,398 | -63,809 | ||
| Change in foreign currency translation | 55 | 62 | ||
| Unrealized (loss), change in fair value of available-for-sale securities, net of tax | -10 | -18 | ||
| Net loss and comprehensive loss | -7,353 | -63,765 | ||
| Earnings per share, basic | -0.01 | -0.07 | ||
| Earnings per share, diluted | -0.01 | -0.07 | ||
| Weighted average number of shares outstanding, basic | 979,949,668 | 979,949,668 | ||
| Weighted average number of shares outstanding, diluted | 979,949,668 | 979,949,668 | ||